Contraception Clinical Trial
Official title:
Immediate Post-placental Insertion of the Copper T 380A After Cesarean Delivery Versus 6 Week Post-cesarean Insertion: A Pilot Randomized Controlled Trial
The purpose of this study is to determine, in a pilot setting, if this study is feasible in
terms of recruitment, willingness to be randomized, provision of contraceptive methods, and
follow-up. The investigators hypothesize that this pilot study will be feasible in terms of
recruitment, provision of care, and follow-up.
The study will be a pilot randomized controlled trial comparing outcomes of immediate
post-placental insertion of the Copper T 380A (Group 1) to outcomes of interval insertion of
the Copper T 380A performed 6 weeks after delivery (Group 2) for patients undergoing
scheduled cesarean delivery at Mulago Hospital in Kampala, Uganda. This study will not be
powered to detect a difference, but rather the investigators will enroll all eligible and
interested women during the three-month enrollment period. Potential participants who do not
choose an IUD or who choose not to participate will be offered an anonymous opt-out survey.
Status | Completed |
Enrollment | 68 |
Est. completion date | November 2011 |
Est. primary completion date | November 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Pregnant at time of enrollment 2. Scheduled to undergo non-emergent cesarean delivery 3. Will have to wait at least 8 hours before their cesarean section 4. Are not in active labor 5. Desires to use the Copper T 380A for contraception 6. Willing and able to sign an informed consent 7. Willing to comply with the study protocol 8. Age greater than or equal to 18 years 9. English or Luganda speaking 10. Willing to be accompanied home upon discharge from the hospital and have their address recorded in order to be able to visit them at home at 6 months postpartum if they do not return for their 6 month follow-up visit. Exclusion Criteria: 1. Allergy to copper or pelvic tuberculosis, severe thrombocytopenia 2. Positive N. gonorrheae or C. trachomatis testing 3. Presence of leiomyomata significantly distorting the uterine cavity and thus not allowing placement of the Copper T 380A 4. Uterine anomaly which would not allow placement of the Copper T 380A 5. Current cervical cancer or carcinoma in-situ 6. Desire for repeat pregnancy in less than 12 months 7. Evidence of intra-uterine infection (Chorioamnionitis) 8. Pre-term birth prior to 34 weeks of gestation 9. Diagnosis of AIDS (HIV is not an exclusion criteria) 10. Fetal demise 11. Antepartum hemorrhage 12. Ruptured uterus 13. Eclampsia 14. Evidence of severe anemia Post enrollment exclusion criteria 1. Group 1: Interval development of any of the above exclusion criteria (New evidence of chorioamnionitis; fetal demise; ruptured uterus; eclampsia; severe anemia) 2. Group 1: Post-partum hemorrhage with continued active bleeding that does not allow placement of the Copper T 380A within 10 minutes of the delivery of the placenta 3. Group 1: Prolonged rupture of membranes > 12 hours 4. Group 2: Diagnosis of active cervical infection within 3 months of planned insertion, or evidence of active pelvic or cervical infection, pus at the cervical os or any concern for upper genital tract infection, including fever (temperature = 38° C) or uterine or adnexal tenderness. Diagnosis of new pregnancy. 5. Group 2: Interval development of any of the above exclusion criteria (i.e. new suspicion of cervical cancer or carcinoma in situ) 6. Both Groups: Participant no longer desires a Copper T 380A |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
Uganda | Mulago Hospital | Kampala |
Lead Sponsor | Collaborator |
---|---|
Planned Parenthood League of Massachusetts | Brigham and Women's Hospital, Mulago Hospital, Uganda, Society of Family Planning |
Uganda,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | 6 month IUD usage rates | The number of participants enrolled who are using the Copper T 380A at 6 months post-delivery. This will include participants who are excluded at time of delivery or interval insertion and participants who do not follow up for interval Copper T 380A insertion | 6 months | No |
Secondary | IUD Expulsion | The time until expulsion of the Copper T 380A will be defined as the time from insertion until expulsion occurred, if known. If the date of expulsion is not known, this will be documented as the day after the IUD was last known to be in place. If a pregnancy is detected and the Copper T 380A is absent (and the participant was unaware of expulsion), the expulsion will be assumed to have occurred at the time of conception, as determined by gestational age on ultrasound. Expulsions will be measured as total expulsions and separately noted whether complete or partial | within 6 months | No |
Secondary | IUD Removal | The proportion of participants who have the Copper T 380A inserted and who deliberately have it removed. We will also analyze the time to removal for these participants | within six months | No |
Secondary | IUD insertion | The proportion of participants receiving a Copper T 380A in each group | within 6 months | No |
Secondary | Pregnancy | Time to pregnancy will be calculated from the date of delivery until the estimated date of conception of a subsequent pregnancy, as based on sonographic dating. If sonographic dating is not available, the date of the last missed menses or three weeks before the first positive urine pregnancy test (if amenorrheic or oligomenorrheic) will be used | within 6 months | No |
Secondary | Infection | The diagnosis of PID will be made based on the 2006 CDC guidelines and the criteria used in the PEACH study | within 6 months | No |
Secondary | Uterine Perforation | The diagnosis of a perforation may be made by a transvaginal sonogram that shows no Copper T 380A within the uterus and an abdominal radiograph that shows a Copper T 380A within the abdominal cavity | within 6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02577601 -
Impact of Combined Hormonal Contraceptives on UPA
|
Phase 4 | |
Completed |
NCT03153644 -
Improving Contraceptive Care for Women With Medical Conditions
|
||
Completed |
NCT04112095 -
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
|
Phase 3 | |
Recruiting |
NCT05521646 -
Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative
|
N/A | |
Active, not recruiting |
NCT04291001 -
Ovarian Function With ENG Implant and UPA Use
|
Early Phase 1 | |
Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
Completed |
NCT03438682 -
Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
|
||
Active, not recruiting |
NCT01948882 -
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
|
N/A | |
Enrolling by invitation |
NCT04997499 -
Adolescent Subcutaneous (SQ) Injection Video Validation
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 | |
Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
Completed |
NCT03154125 -
Sayana® Press Extension Study
|
Phase 3 | |
Withdrawn |
NCT03725358 -
A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon.
|
N/A | |
Completed |
NCT02957630 -
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
|
Phase 1/Phase 2 | |
Completed |
NCT02456584 -
Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
|
Phase 1 | |
Completed |
NCT02718222 -
Impact and Performance of Institutionalizing Immediate Post-partum IUD Services
|
N/A | |
Recruiting |
NCT02121067 -
LNG-IUS at 2 Weeks Postpartum
|
Phase 4 | |
Terminated |
NCT02169869 -
Immediate Postplacental IUD Insertion
|
N/A | |
Recruiting |
NCT02292056 -
Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions
|
N/A | |
Withdrawn |
NCT01930994 -
Kenya Sino-implant (II) PK Study
|
N/A |